Cargando…

Is stiripentol truly effective for treating primary hyperoxaluria?

Detalles Bibliográficos
Autores principales:	Martin-Higueras, Cristina, Feldkötter, Markus, Hoppe, Bernd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857785/ https://www.ncbi.nlm.nih.gov/pubmed/33564453 http://dx.doi.org/10.1093/ckj/sfaa068

Ejemplares similares

Improving Treatment Options for Primary Hyperoxaluria
por: Hoppe, Bernd, et al.
Publicado: (2022)

Diet-related urine collections: assistance in categorization of hyperoxaluria
por: Dill, Hannah, et al.
Publicado: (2021)

Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type I
por: Recker, Pia, et al.
Publicado: (2022)

Pancytopenia as a Complication of Primary Hyperoxaluria
por: Khosravi, M., et al.
Publicado: (2019)

Simple, fast and inexpensive quantification of glycolate in the urine of patients with primary hyperoxaluria type 1
por: Boehm, Thomas, et al.
Publicado: (2023)

Stiripentol for Dravet syndrome
Publicado: (2020)

Is it truly atrial tachycardia?
por: Kaneko, Yoshiaki, et al.
Publicado: (2016)

Kidney Stones in Primary Hyperoxaluria: New Lessons Learnt
por: Jacob, Dorrit E., et al.
Publicado: (2013)

Is flat line truly asystole?
por: Ramanathan, Gayathri, et al.
Publicado: (2015)

To the editor: Is this cutaneous angiomyolipoma truly an angiomyolipoma?
por: Okoń, Krzysztof, et al.
Publicado: (2013)

Is Genotype the Major Outcome Parameter of Kidney Failure in Patients With Primary Hyperoxaluria Type 1?
por: Vali, P. Sharmas, et al.
Publicado: (2023)

A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria
por: Milliner, Dawn, et al.
Publicado: (2017)

Antiepileptic Stiripentol May Influence Bones
por: Matuszewska, Agnieszka, et al.
Publicado: (2021)

The retinal phenotype in primary hyperoxaluria type 2 and 3
por: Birtel, Johannes, et al.
Publicado: (2022)

Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
por: Metry, Elisabeth L., et al.
Publicado: (2023)

Difficult airway: are we ever truly prepared?
por: Gangakhedkar, Gauri Raman
Publicado: (2019)

Commentary: Targeting LDH enzymes with a stiripentol analog to treat epilepsy
por: Cho, Chang-Hoon
Publicado: (2015)

Primary Hyperoxaluria
por: Harambat, Jérôme, et al.
Publicado: (2011)

Clinical and economic impact of primary hyperoxaluria: a retrospective claims analysis
por: Mucha, Lisa, et al.
Publicado: (2022)

Is insulin resistance truly responsible for post-COVID depression?
por: Finsterer, Josef, et al.
Publicado: (2023)

Audit of use of stiripentol in adults with Dravet syndrome
por: Balestrini, S., et al.
Publicado: (2016)

Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria
por: Siener, Roswitha, et al.
Publicado: (2013)

LTE: Does caffeine truly raise muscle carnitine in humans?
por: Constantin‐Teodosiu, Dumitru
Publicado: (2023)

Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry
por: Metry, Elisabeth L., et al.
Publicado: (2021)

Does SARS-CoV-2 truly cause infectious myopathy?
por: Finsterer, Josef, et al.
Publicado: (2021)

Reply to LTE: Does caffeine truly raise muscle carnitine in humans?
por: Wall, Benjamin T., et al.
Publicado: (2023)

Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria
por: Ariceta, Gema, et al.
Publicado: (2021)

Primary hyperoxaluria and systemic oxalosis
por: Sriram, K., et al.
Publicado: (2007)

Can Pediatric Surgeons Become Truly Experienced for Thyroid Surgery on a Universal Scale?
por: İnanç, İrem, et al.
Publicado: (2018)

Quantifying the HDL proteome by mass spectrometry: how many proteins truly associate with HDL?
por: Marsche, Gunther
Publicado: (2018)

“Not everyone deserves the Green Channel”: Self-declaration in the publication is only for the truly mature and honest
por: Karthik, Raghavendhar
Publicado: (2023)

Could the NHS ever be truly independent?
por: Franchi, Thomas, et al.
Publicado: (2020)

Nanoemulsions as novel oral carriers of stiripentol: insights into the protective effect and absorption enhancement
por: Lu, Rong, et al.
Publicado: (2015)

Response to letter to the editor “Does SARS-CoV-2 truly cause infectious myopathy?”
por: Chang, Kai Chieh
Publicado: (2021)

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
por: Lai, Chengjung, et al.
Publicado: (2018)

Infantile Primary Hyperoxaluria Type 1 Treated With Lumasiran in Twin Males
por: Aldabek, Khaled, et al.
Publicado: (2022)

Efficacy of Stiripentol in Dravet Syndrome with or without SCN1A Mutations
por: Cho, Min Jung, et al.
Publicado: (2018)

The Struggling Odyssey of Infantile Primary Hyperoxaluria
por: Guillaume, Adrien, et al.
Publicado: (2021)

Treatment of primary hyperoxaluria type 1
por: Gupta, Asheeta, et al.
Publicado: (2022)

Primary hyperoxaluria: a case series
por: Rather, Jawad Iqbal, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f1a5hams32og8g2hkf3uc1t9qm